2017
DOI: 10.1016/j.ejmp.2017.03.002
|View full text |Cite
|
Sign up to set email alerts
|

Knowledge-based treatment planning: An inter-technique and inter-system feasibility study for prostate cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
35
0

Year Published

2018
2018
2022
2022

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 46 publications
(39 citation statements)
references
References 26 publications
3
35
0
Order By: Relevance
“…The RapidPlan module in Eclipse treatment planning system of version 13.5 or later (Varian Medical Systems, Palo Alto, CA) has commercialized the knowledge‐based solution18, 19 and displayed good compatibility across patient orientations, treatment techniques, and systems 20, 21…”
Section: Introductionmentioning
confidence: 99%
“…The RapidPlan module in Eclipse treatment planning system of version 13.5 or later (Varian Medical Systems, Palo Alto, CA) has commercialized the knowledge‐based solution18, 19 and displayed good compatibility across patient orientations, treatment techniques, and systems 20, 21…”
Section: Introductionmentioning
confidence: 99%
“…This group validated model performance and provided feedback to the final clinical version. Our experience showed that a collaboration of this type has the potential to develop models faster since, as previously been highlighted, Table 3 All development can be time-consuming [27], and more robustly due to the prompt availability and diversity of the plans included in the model training [20]. It was not previously shown that such a heterogeneous input population can be used to create uniform models in a diverse plan environment.…”
Section: Discussionmentioning
confidence: 80%
“…As a critical step towards this objective, an effort was made to reduce variability in treatment planning and improve overall plan quality by introducing automation. These institutions provided clinically approved treatment plans for a range of tumour sites (prostate, head and neck and anal canal [19]), in order to create heterogeneous training datasets, and models, with potential benefits, as previously highlighted [20]. A similar initiative was previously promoted by Schubert et al and Roach et al [21,22], however their models were created using data from a single institution, and then distributed to other centres.…”
Section: Introductionmentioning
confidence: 99%
See 1 more Smart Citation
“…79 To gain further understanding of the overall performance of KBP in prostate cancer planning, we have developed a visualization scheme to provide a summary view of nine KBP prostate studies that compared re-planned results with original clinically approved values. 20,25,27,34,35,56,57,60,63 As mentioned previously, the challenge of summarizing results across all studies lie in two aspects: (a) the results are based on different sample points of the DVH curve and measure changes along different directions (e.g., one study may use D35 while another use V65); (b) some of the studies report only the differences in DVH point metrics (e.g., D35 is reduced by 1.5) without providing the original clinically approved values. The first issue makes it difficult to quantitatively compare results from different studies even though many DVH point metrics assess performance in similar areas of the DVH curve.…”
Section: C Performance Of Kbpmentioning
confidence: 99%